|
30 Jul 2025 |
SRF
|
Consensus Share Price Target
|
3110.00 |
3080.07 |
- |
-0.96 |
hold
|
|
|
|
|
27 Jun 2023
|
SRF
|
Motilal Oswal
|
3110.00
|
2580.00
|
2308.35
(34.73%)
|
Target met |
Neutral
|
|
|
|
|
23 May 2023
|
SRF
|
Chola Wealth Direct
|
3110.00
|
3300.00
|
2470.80
(25.87%)
|
|
Buy
|
|
|
|
|
11 May 2023
|
SRF
|
ICICI Direct
|
3110.00
|
3000.00
|
2560.95
(21.44%)
|
|
Buy
|
|
|
|
|
11 May 2023
|
SRF
|
Edelweiss
|
3110.00
|
2856.00
|
2560.95
(21.44%)
|
|
Buy
|
|
|
Specialty Chemicals Business continues to outperform
|
|
10 May 2023
|
SRF
|
ICICI Securities Limited
|
3110.00
|
2520.00
|
2571.25
(20.95%)
|
Target met |
Hold
|
|
|
SRF’s Q4FY23 print for chemical business (EBIT up 47% YoY) benefited from strong ref gas and fluorospecialty business. Despite the risk of pricing in ref-gas and down- cycle in agro-chemicals, company has guided for chemical segment revenue growth of 20%+, and EBIT margin improvement in FY24 (vs FY23).
|
|
10 May 2023
|
SRF
|
Motilal Oswal
|
3110.00
|
2680.00
|
2571.25
(20.95%)
|
Target met |
Neutral
|
|
|
|
|
14 Mar 2023
|
SRF
|
BP Wealth
|
3110.00
|
2803.00
|
2305.40
(34.90%)
|
|
Buy
|
|
|
|
|
01 Feb 2023
|
SRF
|
ICICI Direct
|
3110.00
|
2550.00
|
2224.65
(39.80%)
|
Target met |
Buy
|
|
|
|
|
31 Jan 2023
|
SRF
|
ICICI Securities Limited
|
3110.00
|
2220.00
|
2182.45
(42.50%)
|
Target met |
Hold
|
|
|
SRF’s Q3FY23 print for chemical business (EBIT up 35% YoY) establishes its ability to drive strong growth despite challenging times, driven by balanced product mix and capacity expansion at an opportune time. It is now expanding fluorocarbon business with the addition of fluoropolymers, again, at the right time when cycle is about to turn favourable in this category.
|
|
31 Jan 2023
|
SRF
|
Motilal Oswal
|
3110.00
|
2450.00
|
2182.45
(42.50%)
|
Target met |
Neutral
|
|
|
|